
oct pm et
summari compani lead supplier health care inform technolog hcit solut
health care devic relat servic
price-to-earnings oper ep
posit hcit market broad custom base
weigh highli competit environ
product servic well risk technolog
oct ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
aug stock trade
star recommend
recent chang hold
buy target price
recent chang
highlight section stock report
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
twelve-month target
next-twelve-month ep estim
multipl slightli cern
five-year averag forward multipl ratio
lower ep estim
think
hcit market becom increasingli
satur competit well-fund
player
privately-held epic system
growth pressur especi given defer
revenu growth lag revenu growth
book also declin year-over-year
term upsid could see increas
cross-sal opportun particularli
relat popul health manag
grow area interest hcit field /kevin
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview corp largest stand-alone health care inform technolog hcit
compani provid health care inform technolog solut devic relat servic
health care organ consum domest revenu account
compani total howev februari acquisit siemen health system expand
revenu deriv system sale support mainten servic sale includ sale
softwar deploy period upgrad right instal fee content subscript transact
process hardwar sublicens softwar support mainten servic includ on-going
support servic provid client servic includ profession servic exclud instal
manag servic reimburs travel includ reimburs out-of-pocket expens relat
client servic activ account remain
corpor strategi intend increas market share provid innov solut
servic exist new client well captur potenti client wish upgrad
system avail incent offer health inform technolog
econom clinic health act high-tech provis american recoveri reinvest act
current oper countri plan increas sale outsid
countri realiz import hcit also expect increas market share make
offer afford smaller commun hospit critic access hospit physician practic
well sell softwar servic also plan offer solut beyond hcit market similar
current offer form clinic pharmaci well servic provid directli employ
impact major develop high-tech provis within arra expect drive demand
hcit solut provid billion financi incent encourag health care
organ acquir adopt hcit incent avail start elig
profession must qualifi receiv maximum incent four year
hospit must qualifi receiv maximum estim incent million
four year care organ subject penalti begin fail adopt hcit
juli depart human servic issu final meaning use rule
hospit meet core requir elig profession -- doctor nurs
center medicar medicaid servic decid defin meaning use use
three-stag criteria stage one focu record health inform code format use
inform track condit coordin care implement clinic decis support tool
facilit diseas medic manag report clinic qualiti measur pubic health
inform goal stage improv qualiti care exchang
inform code format interoper among differ electron health record system
stage three improv qualiti safeti effici decision-support tool patient
compani approach popul health enabl organ know happen
predict would happen within popul solut data exchang longitudin
record enterpris data warehous analyt qualiti regulatori report engag provid
patient health care deliveri person health portal solut care manag
home care long-term care retail pharmaci manag health improv care capac
workforc manag clinic research predict model health registri contract network
manag solut enabl healtheint platform multi-purpos
programm platform scale popul level facilit health care person
provid level cloud-bas platform enabl organ aggreg transform reconcil
data across continuum care healtheint abl receiv data ehr exist hcit
system data sourc pharmaci benefit manag insur claim healtheint
collect data multipl dispar sourc near real-tim provid clariti variou data point
action programm workflow enabl organ identifi score predict risk
individu patient allow match right care program right individu
ehr-agnost natur healtheint platform allow offer solut entir marketplac
financi trend three-year period sale grew billion billion
repres compound annual growth rate compound-annual-growth-rate oper margin fluctuat
sale growth oper leverag off-set lower margin system
resal sale lower margin acquisit siemen health system ep inclus stock
grew repres compound-annual-growth-rate
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
under-valued
neutral sinc octob technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
reimburs fee-for-servic basi rather
compani paid base qualiti
effect care value-bas
part physician qualiti report
valu modif medicar
program one mip reimburs
base qualiti resourc use clinic
practic improv meaning use
year date septemb
vs rise composit
 health
technolog index rose vs rise
neutral fundament outlook
health care technolog sub-industri next
month think near-term hcit
demand difficult forecast
care technolog hcit also matur
industri seen substanti growth
last sever year us
govern health inform technolog
econom clinic health high-tech act
effect offer financi
incent hospit physician adopt
util health care inform technolog
due recent industri consolid compani
offer hcit solut cater smaller
compani pressur compani
space differenti correctli
anticip regulatori chang offer
better analyt tool drive effort
popul health manag
high-tech act elig doctor
incent adopt health care inform
technolog equip servic high-tech
act drove demand hcit solut
provid billion financi incent
five year encourag health care
organ adopt effect hcit
incent avail start
elig profession qualifi
receiv maximum incent
five year hospit
qualifi receiv
maximum estim incent million
medicar access chip reauthor
act macra becam effect
macra replac sustain growth
rate sgr formula determin medicar
part reimburs rate physician
replac new payment method
macra health care provid
base index
five-year market price perform oct
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
sign result see book believ
aggress backlog rose /jeffrey loo cfa
keep target price peer
forward ep estim ep vs
in-lin estim sale rose book rose robust
billion drive backlog billion encourag
book believ continu gain market share
book came outsid core millennium instal base also
establish relationship lifepoint health small group
facil think contract could expand time /jeffrey loo
rais target peer
ep estim near mid-point rang
ep vs ahead estim sale rose
driven strong growth system sale servic sale
book rose drive backlog growth billion
encourag cern sale book metric follow sever
soft quarter howev note face tough book compar
see book /jeffrey loo cfa
analyst research note compani news
hold buy lower twelve-month target
next-twelve-month ep estim multipl slightli
cern five-year averag forward multipl ratio
lower ep estim think
matur health care inform technolog hcit market becom
increasingli satur competit well-fund player
privately-held epic system
defer revenu growth lag revenu growth book also
declin year-over-year term upsid could see increas
cross-sal opportun particularli relat popul health
manag grow area interest hcit field /kevin huang cfa
rais target price
line peer forward ep estim near
mid point five-year rang ep vs
ahead estim rais ep estim
sale rose softwar sale tech resal sale
profession servic manag servic support
mainten book robust well ahead
forecast mainli initi task order new veteran affair
contract sign may total backlog
encourag robust book quarter look continu
robust book anticip order veteran affair
contract could lumpi futur quarter also see addit opportun
feder busi includ potenti expand depart
et cfra keep buy opinion share corpor
lower target slightli
peer ep view near low end
five-year rang ep vs line
estim although see volatil share due
uncertainti delay relat veteran administr contract note
continu strong book backlog expect
contract depart veteran affair sign
would like small contribut result delay
relat chang leadership veteran administr
believ contract eventu sign book drove
backlog sale rose softwar sale technolog
re-sal profession servic manag servic
support mainten geograph sale flat
et cfra lift opinion share corpor buy
hold rais target
peer ep estim midpoint
five-year rang set ep vs
estim partli product mix lower margin
slightli higher oper cost relat up-front invest although
expect continu pressur oper margin product mix increas
invest think share trade ep estim
attract valu also encourag book
keep target price above-p
forward ep estim ep vs
estim lower ep estim
book significantli
year ago expect book say
expect sever larg contract expect sign
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
